Clinical Trials Directory

Trials / Completed

CompletedNCT05872178

Omegia Softgel Clinical Research Program

Chia Nan University of Pharmacy & Science

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Chia Nan University of Pharmacy & Science · Academic / Other
Sex
Female
Age
45 Years – 75 Years
Healthy volunteers
Accepted

Summary

Evaluate the improvement of regulation of skin and blood index composition after consumption of Omegia® Softgel

Detailed description

The blood biochemical analysis at Weeks 0 and 12, including Catalase, Tumor necrosis factor-α, Cholesterol, Triglyceride, High-density lipoprotein-Cholesterol and Low-density lipoprotein- Cholesterol. The Skin assessment at Weeks 0, 4 and 12, including Skin brightness, Skin redness sensitivity index, Skin moisture, Skin elasticity, Facial skin pores, Facial skin texture and Skin collagen content.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTOmegia® Softgel -BHow to use: Take once a day for 12 weeks Subject precautions: If the health products and cosmetic care products used contain sea buckthorn ingredients, stop using them.
DIETARY_SUPPLEMENTOmegia® Softgel -AHow to use: Take once a day for 12 weeks Subject precautions: If the health products and cosmetic care products used contain sea buckthorn ingredients, stop using them.

Timeline

Start date
2021-04-15
Primary completion
2022-12-31
Completion
2022-12-31
First posted
2023-05-24
Last updated
2023-05-24

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT05872178. Inclusion in this directory is not an endorsement.

Omegia Softgel Clinical Research Program (NCT05872178) · Clinical Trials Directory